Clinical Trials in North Carolina

Showing 2821-2840 of 9,731 trials

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

NCT06087406

The purpose of this study is to determine the safety and tolerability of imvotamab in patients with moderate to severe rheumatoid arthritis who have failed prior therapies. Participants will be given imvotamab or placebo through a vein (i.e., intravenously). A placebo is a look-alike substance that contains no active drug

Rheumatoid ArthritisArthritis, RheumatoidArthritis

IGM Biosciences, Inc.33 participantsStarted Mar 2023

Flagstaff, Arizona, United States • Glendale, Arizona, United States • San Diego, California, United States +15 more locations

COMPLETEDNA46 miles

Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes

NCT04342260

This study is designed to test if patient-reported outcomes with automated reporting to clinicians for remote monitoring of postoperative symptoms is feasible and improves quality of life, health outcomes, and service utilization in thoracic surgery patients. Patients undergoing thoracic surgery will be asked to self-report symptoms for remote monitoring by their care team.

Thoracic Surgery

UNC Lineberger Comprehensive Cancer Center113 participantsStarted Apr 2020

Chapel Hill, North Carolina, United States

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes

Find Trials by Condition in North Carolina

Communication During Hospitalization About Resuscitation Trial

Neuroblastoma Precision Trial

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications

Persona Partial Knee Clinical Outcomes Study

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

Living WELL: A Web-Based Program for Ovarian Cancer Survivors